(Q48327747)

10 February 2018

title

Does increased platelet release of Abeta peptide contribute to brain abnormalities in individuals with depression? (English)

1 reference

10 February 2018

author

Nunzio Pomara

series ordinal

1

1 reference

10 February 2018

author name string

P Murali Doraiswamy

series ordinal

2

1 reference

10 February 2018

publication date

1 May 2003

1 reference

10 February 2018

published in

Medical Hypotheses

1 reference

10 February 2018

volume

60

1 reference

10 February 2018

issue

5

1 reference

10 February 2018

page(s)

640-643

1 reference

10 February 2018

Depression in late life, cognitive decline and white matter pathology in two clinico-pathologically investigated cases

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Reduction of orbital frontal cortex volume in geriatric depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Depression, cerebral atrophy, cognitive performance and incidence of dementia. Population study of 85-year-olds

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Qualitative magnetic resonance imaging findings in geriatric depression. Possible link between later-onset depression and Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

The prevalence of depression in relation to cerebral atrophy and cognitive performance in 70- and 74-year-old women in Gothenburg. The Women's Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Brain imaging abnormalities in mental disorders of late life.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

MRI findings in patients with affective disorder: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Neuroimaging studies of mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Late-onset depression: genetic, vascular and clinical contributions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Neuroanatomical substrates of depression in the elderly.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: a preliminary positron emission tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Clinically defined vascular depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

MRI-defined vascular depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Exaggerated platelet reactivity in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Platelet reactivity in depressed patients treated with paroxetine: preliminary findings

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Platelet activation in depression and effects of sertraline treatment: An open-label study

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Increased platelet aggregability in major depression?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Elevated P-selectin on platelets in depression: response to bupropion

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Influence of serotonin-transporter-linked promoter region polymorphism on platelet activation in geriatric depression

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Platelet supersensitivity to thrombin stimulation in depression: a possible mechanism for the association with cardiovascular mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Protease nexin-2/amyloid beta-protein precursor in blood is a platelet-specific protein

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Platelets as a peripheral district where to study pathogenetic mechanisms of alzheimer disease: the case of amyloid precursor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Amyloid precursor protein and amyloid beta peptide in human platelets. Role of cyclooxygenase and protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Study of platelet-mediated neurotoxicity in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Platelet secretory products may contribute to neuronal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Blood-brain barrier transport of circulating Alzheimer's amyloid beta

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Increased plasma amyloid beta protein 1-42 levels in Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Plasma levels of amyloid beta proteins Abeta1-40 and Abeta1-42(43) are elevated in Down's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Elevated plasma amyloid beta-peptide 1-42 and onset of dementia in adults with Down syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Chronic corticosterone administration dose-dependently modulates Abeta(1-42)- and NMDA-induced neurodegeneration in rat magnocellular nucleus basalis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

Selective serotonin reuptake inhibitors and myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2802%2900380-8

7 January 2021

10.1016/S0306-9877(02)00380-8

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018